中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2010年
2期
309-312
,共4页
气管移植%种子细胞%气管组织工程%综述文献
氣管移植%種子細胞%氣管組織工程%綜述文獻
기관이식%충자세포%기관조직공정%종술문헌
背景:以组织工程气管作为移植气管,不但能降低抗原细胞的表达,抑制免疫反应,还能够预先在体外进行气管的血管化以及相关组织细胞的再生培养.目的:总结归纳常用的气管移植的方法,介绍组织工程气管的最新临床移植方式,为开展该类手术提供参考依据.方法:以tissue engineering,trachea,transplantation为检索词,检索Pubmed数据库(1990-01/2009-05),ScienceDirect数据库(1990-01/2009-05),Springer数据库(1990-01/2009-05);以组织工程学,气管,移植为检索词,检索CNKI数据库(1990-01/2009-05).文献检索语种限制为英文和中文.纳入与气管移植相关的临床研究和动物实验;排除重复文献.结果与结论:计算机初检得到270篇文献,根据纳入排除标准,对其中32篇文献进行分析.由于各种原因引起的气管不可逆性损伤且需移植置换的情况在临床工作中日趋增多,而移植气管的材料来源一直是制约临床气管移植的主要问题.体外构建组织工程气管用于移植被视为气管修复的有效途径.文章对气管移植及组织工程气管的起源与发展进行回顾,且对近年来较常用的同种异体移植,自体组织移植及生物材料移植等方法,生物支架材料的构建研究,种子细胞的选取研究,组织工程气管的临床应用进展等进行简要叙述,并对最新的利用同种异体气管与剔除供者免疫细胞进行种子细胞培养相结合的方法,成功完成全球首例人造气管移植的案例进行着重的介绍.
揹景:以組織工程氣管作為移植氣管,不但能降低抗原細胞的錶達,抑製免疫反應,還能夠預先在體外進行氣管的血管化以及相關組織細胞的再生培養.目的:總結歸納常用的氣管移植的方法,介紹組織工程氣管的最新臨床移植方式,為開展該類手術提供參攷依據.方法:以tissue engineering,trachea,transplantation為檢索詞,檢索Pubmed數據庫(1990-01/2009-05),ScienceDirect數據庫(1990-01/2009-05),Springer數據庫(1990-01/2009-05);以組織工程學,氣管,移植為檢索詞,檢索CNKI數據庫(1990-01/2009-05).文獻檢索語種限製為英文和中文.納入與氣管移植相關的臨床研究和動物實驗;排除重複文獻.結果與結論:計算機初檢得到270篇文獻,根據納入排除標準,對其中32篇文獻進行分析.由于各種原因引起的氣管不可逆性損傷且需移植置換的情況在臨床工作中日趨增多,而移植氣管的材料來源一直是製約臨床氣管移植的主要問題.體外構建組織工程氣管用于移植被視為氣管脩複的有效途徑.文章對氣管移植及組織工程氣管的起源與髮展進行迴顧,且對近年來較常用的同種異體移植,自體組織移植及生物材料移植等方法,生物支架材料的構建研究,種子細胞的選取研究,組織工程氣管的臨床應用進展等進行簡要敘述,併對最新的利用同種異體氣管與剔除供者免疫細胞進行種子細胞培養相結閤的方法,成功完成全毬首例人造氣管移植的案例進行著重的介紹.
배경:이조직공정기관작위이식기관,불단능강저항원세포적표체,억제면역반응,환능구예선재체외진행기관적혈관화이급상관조직세포적재생배양.목적:총결귀납상용적기관이식적방법,개소조직공정기관적최신림상이식방식,위개전해류수술제공삼고의거.방법:이tissue engineering,trachea,transplantation위검색사,검색Pubmed수거고(1990-01/2009-05),ScienceDirect수거고(1990-01/2009-05),Springer수거고(1990-01/2009-05);이조직공정학,기관,이식위검색사,검색CNKI수거고(1990-01/2009-05).문헌검색어충한제위영문화중문.납입여기관이식상관적림상연구화동물실험;배제중복문헌.결과여결론:계산궤초검득도270편문헌,근거납입배제표준,대기중32편문헌진행분석.유우각충원인인기적기관불가역성손상차수이식치환적정황재림상공작중일추증다,이이식기관적재료래원일직시제약림상기관이식적주요문제.체외구건조직공정기관용우이식피시위기관수복적유효도경.문장대기관이식급조직공정기관적기원여발전진행회고,차대근년래교상용적동충이체이식,자체조직이식급생물재료이식등방법,생물지가재료적구건연구,충자세포적선취연구,조직공정기관적림상응용진전등진행간요서술,병대최신적이용동충이체기관여척제공자면역세포진행충자세포배양상결합적방법,성공완성전구수례인조기관이식적안례진행착중적개소.
BACKGROUND: Tissue-engineered trachea serving as a tracheal transplant, can not only reduce the expression of antigen cells, suppress immunoreaction, but also in advance conduct vascularization of blood vessels and regeneration culture of tissue cells in vitro. OBJECTIVE: To summarize the commonly used methods for tracheal transplantation, to introduce the latest clinical transplantation method of tissue-engineered trachea, and to provide reference evidence for carrying out such operations. METHODS: Taking tissue engineering, trachea, transplantation in English as search terms, Pubrned database from January 1990 to May 2009, ScienceDirect database from January 1990 to May 2009, Springer database from January 1990 to May 2009 was retrieved; Taking tissue engineering, trachea, transplantation in Chinese as search terms, CNKI database from January 1990 to May 2009 was researched. Literatures were limited to English and Chinese languages. Inclusive criteria: clinical studies and animal experiments related to the tracheal transplantation; exclusive criteria: duplicate documents. RESULTS AND CONCLUSION: Totally 270 literatures were screened out by computer, accordingto inclusion and exclusion criteria, 32 documents of which were involved for analysis. There is an increasing cases with irreversible injury of tracheal resulted from various reasons and in need of transplantation during clinical work, and the material source of tracheal transplantation is always the main problem to limited the clinical use. Constructing tissue-engineered trachea in vitro is considered to be a good way for repairing trachea. This paper will review the origin and development of tracheal transplantation and tissue-engineered trachea, summarize the common method of allotransplantation, autotransplantation and biomaterial transplantation, as well as the research of constructing bio-scaffold, choosing seed cells and clinical applied development of tissue-engineered trachea, and emphatically introduce the first case of successful artificial tracheal transplantation by combining the method of allotransplantation and culturing the seed cell without the immune cells of donor.